Skip to main content
Caplight Logo









PharmaCann Global

PharmaCann Global

Private
Gold CoastHealthcare & Life Scienceshttps://www.pharmacann.com.au/

Last Round

IPO

Aug 1, 2021

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PharmaCann Global is a medicinal cannabis company that specializes in the wholesale, distribution, and supply of natural medicines and cannabis products to pharmacies and patients in Australia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medicinal cannabiscannabis wholesalermedical cannabis supplymedical marijuanaCBD productsSASSpecial Access Schemecannabinoid medicineTHC flowerpharmaceutical distributionplant-to-patientclinical researchpractitioner education

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharmaCann Global Comparables

Compare PharmaCann Global with similar companies based on industry and business-model similarity.

PharmaCann Global comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medcan Australia
84%
Cymra Life Sciences
82%
Tasmanian Botanics
80%

PharmaCann Global Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOAug 1, 2021
VC RoundMar 22, 2018

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 46% MoM.

  • Apr 17, 2026

    Monthly visitors increased 52% MoM, reaching 9.4K.

PharmaCann Global Filings

Explore SEC and related filing metadata, where available.

PharmaCann Global filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PharmaCann Global's valuation, stock price, and market status.

Is PharmaCann Global a public or private company?

PharmaCann Global is a private company.

What is the current stock price of PharmaCann Global?

PharmaCann Global is a private company with no public stock price. Caplight tracks PharmaCann Global's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is PharmaCann Global worth (valuation)?

Valuation information for PharmaCann Global is not publicly available.

Can I buy PharmaCann Global stock?

PharmaCann Global shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PharmaCann Global's last funding round?

PharmaCann Global's most recent funding round was IPO on August 1, 2021.

Who are the main investors in PharmaCann Global?

Investor information for PharmaCann Global is not publicly disclosed.

Will PharmaCann Global IPO soon?

No public IPO plans have been announced for PharmaCann Global.

How can I track PharmaCann Global secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PharmaCann Global's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGold Coast
Employee Range1
Year Founded2017
Last FundingAug 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?